Vernalis
Cambridge, United Kingdom vernalis.com From their website, Nov 2026
Work here? Claim this listing
About
Vernalis is a drug discovery CRO that works with biotech, pharma and other collaborators on early discovery programs from hit identification to candidate selection. It provides integrated services in protein sciences, screening, structural biology, chemistry, biophysics, cell biology, ADME/DMPK, informatics and in vivo pharmacology from its site in Cambridge, United Kingdom.
Services
Protein Sciences
Produces and characterises proteins for drug discovery, including construct design, expression and purification across multiple systems.
Protein production
Hit Identification Services
Finds starting points for targets using biochemical assays, DEL, ASMS, in silico screening and fragment-based drug discovery.
Hit ID Platform
Provides end-to-end hit identification across multiple screening platforms.
Chemistry / Hit to Lead Services
Designs, synthesises and optimises compounds from fragment hits to lead series and beyond.
Structural Biology Services
Determines protein and ligand-protein structures using X-ray crystallography and NMR to guide drug design.
Biophysical Screening Services
Validates and characterises hits using NMR, SPR, ITC, MST, TSA and ASMS.
Drug Discovery Informatics
Applies cheminformatics, data science and software engineering to support data-driven discovery decisions.
Cell Biology Services
Runs cell-based assays to assess target engagement, compound activity and mechanism of action.
10 more services
- ADME DMPK Services
- In Vivo Pharmacology Services
- DEL Technology
- PAC-FragmentDEL
- Fragment-Based Drug Discovery
- Protein Science
- Hit ID and Assay
- Biophysics and Structural Biology
- Chemistry and Computational
- DMPK
- What to send
- Minimal protein requirement for PAC-FragmentDEL
- Small amounts of target protein for PAC-FragmentDEL
Capabilities
As they state on their website or in their listing.
- Processes
- Small molecule
- Peptide
- NMR
- SPR
- Biochemical assays
- Mammalian expression
- Insect cells
- Capacity
- Screening billions of compounds in one experiment
- Over 8,000 crystal structures determined for more than 70 targets
- Multiple expression systems: E. coli, yeast, insect and mammalian cell
- Milligram-to-kilogram capabilities
- Bioreactor for precise control of growth conditions and optimal yield
- 50k lead-like chemical space screening library
- Data supplied
- NMR
Equipment
- Biacore T200
- Biacore 1S+
- Biacore 8K
- Bruker D8 venture
- LC-MS/MS
- LCMS-MS
12 more
- NMR
- SPR
- ITC
- MST
- TSA
- ASMS
- X-ray crystallography
- Next Generation Sequencing
- ÄKTA Pure
- ÄKTA Avant
- Agilent QTOF
- Syrris Asia flow chemistry systems
Materials
- Yeast
- Insect cells
Industries served
- Biotech
- Pharma
Details
- Type
- CRO
- Founded
- 2001
- Size
- 51-200 employees
- Address
- 01 Find Us Granta Park is just 8 miles from Cambridge city centre, 20 minutes from London St
Public records
- Wikidata
- Q7921942 source